Dihydroberberine

Overview

Dihydroberberine is a naturally occurring isoquinoline alkaloid with anti-inflammatory, anti-atherosclerotic, hypolipidemic and anti-tumor activities. Dihydroberberine inhibits the human ether-related gene ( hERG ) channel and significantly reduces the expression of heat shock protein 90 ( Hsp90 ) and its interaction with hERG. Dihydroberberine also blocks the TLR4/MyD88/NF-κB signaling pathway to reduce pro-inflammatory cytokines and immunoglobulins, and has inhibitory effects on DSS ( HY-116282C )-induced experimental colitis. Dihydroberberine also increases the sensitivity of lung cancer to sunitinib ( HY-10255A ), with synergistic efficacy.

Application

Products | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Potassium Channel | Products > Signaling Pathways > HSP

Product Information

• Catalog No.: HY-N1934
• CAS No.: 483-15-8
• Molecular Formula: C20H19NO4
• Molecular Weight: 337.37
• Purity: 99.30%
• Storage: 4°C, sealed storage, away from moisture and light * The compound is unstable in solutions, freshly prepared is recommended.
• Solubility: ≥ 2 mg/mL (5.93 mM); Clear solution
• Availability: In-stock

Source

Original product source